In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

Published Date: 20 Oct 2023

Obesity is a significant risk factor for breast cancer recurrence, according to a recent cohort study by the Danish Breast Cancer Group.

Read Full News

Latest News

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Cognitive Therapy Boosts Brain Function in Schizophrenia

Structured cognitive remediation therapy helps boost brain activity, working memory, and quality of life and reduce severity of symptoms in patients with schizophrenia, a trial shows.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

(This Aug 27 story has been republished, with no changes to text.)

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Structured cognitive remediation therapy helps boost brain activity, working memory, and quality of life and reduce severity of symptoms in patients with schizophrenia, a trial shows.

News All Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Half of procedures occurred in settings not supported by guidelines

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Health news and commentary gathered by MedPage Today staff

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

News, features, and commentary about cancer-related issues

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

Testing could give doctors an early start on life-preserving cancer treatments

SBRT Misses the Mark in Prostate Cancer Trial

No improvement over intensity-modulated RT in urinary symptoms after 2 years, DFS after 3 years

What Caused This Young Man's Bladder Cancer

Occupational exposure, family history make tempting hypotheses

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Soared past 90% in VA system for low-risk disease, to 61% for favorable intermediate-risk disease

Melanoma Patient on Immunotherapy Develops Severe Dermatitis

Clinicians faced with presumed dermatologic AEs urged to consider all differentials

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

News, features, and commentary about cancer-related issues

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Assisted Dying Under Scrutiny From Medscape's Readers

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

3.

Who Bears the Cost of "Forever Chemical" Cleanup?

4.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

5.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

1.

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape

2.

IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights

3.

Subchorionic Hematoma: Causes, Symptoms, and Treatment

4.

Remote Monitoring of Hematologic Recovery Patterns

5.

The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Innovations in Hematology

2.

Thromboprophylaxis In Medical Settings

3.

Common Cancer Myths Debunked

4.

Thromboprophylaxis In Medical Settings- An Update

5.

When Unexplained Bruising May Require Blood Testing

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

Latest News

‘Modest’ Differences in OAT Should Not Obscure Benefits

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

Alzheimer's Blood Test Gets FDA Clearance

Less Seniors Taking Inappropriate Cognitive Meds

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

Cognitive Therapy Boosts Brain Function in Schizophrenia

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Latest News

News All Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

SBRT Misses the Mark in Prostate Cancer Trial

What Caused This Young Man's Bladder Cancer

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Melanoma Patient on Immunotherapy Develops Severe Dermatitis

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

US Mental Health Treatment Rates Rise But Gaps Persist

Cognitive Bias Modification App Fosters Alcohol Avoidance

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Recommended News For You

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

Many Americans unaware of links between HPV and cancers, poll reveals

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?